In this study we also tested the effect of COX inhibitors in an IL-23–induced psoriasis model and found that COX inhibitors are as potent as EP2 and EP4 antagonists in suppressing psoriasis-like skin inflammation in this model. Here, PTGER4 is linked to psoriasis.